Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-03-12

Clinical Trial Update: Transitioning to a Valve -Gated Intrathecal Drug Delivery System (IDDS) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a valve-gated intrathecal drug delivery system for chronic and intractable pain has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rush University Medical Center | Conditions: Chronic Pain, Intractable Pain | Phase 4 | Status: WITHDRAWN